Enanta Pharmaceuticals ENTA
NASDAQ ENTA
$11.60 +0.38 (+3.39%)
At close: Nov 11, 2026 · 4:00 PM EST

Enanta Pharmaceuticals (ENTA) Depreciation and Depletion (2021 - 2022)

Updated

Analysis

Enanta Pharmaceuticals (ENTA) Depreciation and Depletion (2021 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Enanta Pharmaceuticals 326.73 Mn -401.27 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 -88,000.00
Sep 30, 2021 -684,000.00
API Access

Enanta Pharmaceuticals Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=ENTA&period=max&api_key=YOUR_API_KEY